by Peter Ciszewski | Jan 26, 2021
Susan Samson, MD, PhD discusses how to define treatment success when caring for patients with acromegaly. Acromegaly is a rare endocrine disorder usually caused by a benign pituitary tumor and is characterized by excess production of growth hormone and insulin-like...
by Peter Ciszewski | Jan 25, 2021
James Underberg, MD, past-President of the National Lipid Association (NLA) and Clinical Assistant Professor at NYU Medical School discusses the guidelines for managing homozygous familial hypercholesterolemia (HoFH). HoFH is an inherited lipid disorder that...
by Peter Ciszewski | Jan 23, 2021
Auris Huen, MD, PharmD, Assistant Professor, MD Anderson Cancer Center, Department of Dermatology provides an overview of cutaneous T-cell lymphoma (CTCL). Cutaneous T-cell lymphoma belongs to the non-Hodgkin lymphoma class of hematologic T-cell lymphoproliferative...
by Peter Ciszewski | Jan 20, 2021
Gina Glass, Executive Director and Founder of Dreamsickle Kids Foundation, describes a crisis which inspired her to create the patient advocacy group. Sickle cell disease is an inherited blood disorder. Symptoms usually begin in childhood and include swelling,...
by Peter Ciszewski | Jan 19, 2021
Mark Wildgust, PhD, Vice President, Oncology Global Media Affairs at Janssen, discusses positive data from the CARTITUDE-1 study assessing ciltacabtagene autoleucel (cilta-cel) for the treatment of adults with relapsed and/or refractory multiple myeloma....
